Chenchen Liu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
MIER2/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma.
Journal: Journal of advanced research
Published: February 04, 2024
Characterization of Mitoribosomal Small Subunit unit genes related immune and pharmacogenomic landscapes in renal cell carcinoma.
Journal: IUBMB life
Published: January 16, 2024
Biomimetic Theranostic Agents with Superior NIR-II Photoacoustic and Magnetic Resonance Imaging Performance for Targeted Photothermal Therapy of Prostate Cancer.
Journal: Pharmaceutics
Published: May 05, 2023
Single-dye NIR-II chemiluminescence system for H2O2 imaging.
Journal: Chemical communications (Cambridge, England)
Published: March 29, 2023
Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer.
Journal: Frontiers in oncology
Published: December 23, 2022
AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis.
Journal: International journal of biological sciences
Published: October 13, 2022
Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression.
Journal: Annals of translational medicine
Published: May 02, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026